FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
-
Mar 10, 2026, 6:21 pm91 ptsThe U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and Wegovy. The FDA wrote in a March 5 letter that it observed “serious…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.







